Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Rises By 83.5%

Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 247,000 shares, a growth of 83.5% from the March 15th total of 134,600 shares. Based on an average trading volume of 200 shares, the days-to-cover ratio is presently 1,235.0 days. Approximately 0.2% of the shares of the company are sold short.

Oxford Biomedica Price Performance

OTCMKTS:OXBDF traded down $0.17 during trading hours on Wednesday, reaching $3.95. 150,000 shares of the company's stock were exchanged, compared to its average volume of 14,033. Oxford Biomedica has a 1-year low of $2.72 and a 1-year high of $5.68. The company has a quick ratio of 2.07, a current ratio of 2.35 and a debt-to-equity ratio of 1.48. The company has a 50-day moving average of $3.86 and a 200 day moving average of $4.75.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.